Matthew P Delisa

Title: Matthew P. Delisa: Innovator in Cell-Free Glycoprotein Synthesis

Introduction

Matthew P. Delisa is a prominent inventor based in Ithaca, NY (US). He has made significant contributions to the field of biotechnology, particularly in the area of cell-free glycoprotein synthesis. With a total of 2 patents, Delisa's work has the potential to impact vaccine development and protein engineering.

Latest Patents

Delisa's latest patents include groundbreaking methods for synthesizing glycoproteins. One of his patents focuses on "Cell-free glycoprotein synthesis (CFGPS) in prokaryotic cell lysates enriched with components for glycosylation." This patent discloses components and systems that utilize engineered prokaryotic cell lysates to enable the synthesis of glycoproteins. Another significant patent is for "Bioconjugate vaccines' synthesis in prokaryotic cell lysates." This patent outlines methods and systems for synthesizing glycosylated proteins that can be used in vaccines, including anti-bacterial vaccines.

Career Highlights

Matthew P. Delisa has held positions at prestigious institutions such as Northwestern University and Cornell University. His work at these universities has allowed him to advance research in glycoprotein synthesis and contribute to the scientific community.

Collaborations

Delisa has collaborated with notable colleagues, including Michael Christopher Jewett and Jessica Carol Stark. These collaborations have further enriched his research and innovation in the field.

Conclusion

Matthew P. Delisa is a key figure in the advancement of cell-free glycoprotein synthesis, with patents that hold promise for future vaccine development. His contributions to biotechnology continue to pave the way for innovative solutions in protein engineering.